Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Irvine, California
Dates
study started
estimated completion
Principal Investigator
by John Billimek, PhD
Photo of John Billimek
John Billimek

Description

Summary

The purpose of this study is to compare the effect of two educational interventions on adherence to blood pressure medications among adults with uncontrolled hypertension.

Official Title

Mi Propio Camino (Finding My Own Way): Personalized Approaches to Improve Blood Pressure Control

Details

The study is a randomized controlled trial (RCT) consisting of a 4-session educational intervention (completed over the course of 4-8 weeks) and a 6-month follow-up period for adherence monitoring. Participants will be allocated to one of two educational intervention groups following a block randomization schedule, stratified on the hypothesized mediator variable of medication-related beliefs (high versus low scores on the BMQ Necessity-Concerns subscore) to ensure the groups are balanced on this variable. Primary endpoint is medication adherence at 6 month follow-up, defined as the proportion of days that the prescribed number of doses was taken by the patient during a 30-day period, measured by a pill bottle cap monitor (medication events monitoring device [MEMS]).

Keywords

Hypertension Medication Adherence Mi Propio Camino (MPC) Mi Propio Camino (MPC; My Own Way)

Eligibility

You can join if…

Open to people ages 18 years and up

are: (1) age 18 years or greater, (2) uncontrolled hypertension (BP above 140/90 mmHg), (3) Hispanic ethnicity, (4) Spanish or English-speaking, (5) at least one office visit at the study clinic in prior 12 months.

You CAN'T join if...

Persons with stage 4 or 5 chronic kidney disease (CKD) will be excluded.

Location

  • Health Policy Research Institute accepting new patients
    Irvine California 92697 United States

Lead Scientist at UC Irvine

  • John Billimek, PhD
    Associate Professor, Family Medicine. Authored (or co-authored) 52 research publications.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT04585594
Study Type
Interventional
Last Updated